Eli Lilly, Trump and Novo Nordisk
Digest more
Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.
Eli Lilly is expanding its Kenosha County campus with plans to construct six new buildings adjacent to the former Nexus Pharmaceuticals site.
Eli Lilly stock recently achieved a significant milestone, reaching a 52-week high of $935.68, with shares now trading at $935.97. This marks a notable achievement for the pharmaceutical giant, reflecting a strong performance over the past year.
U.S. sales of Lilly’s weight-loss treatment Zepbound nearly tripled, to $3.57 billion, in the third quarter. Meanwhile, revenue from the diabetes drug Mounjaro, which has been on the market longer, has doubled, to $6.52 billion, thanks to growth outside the U.S.
Drug company Eli Lilly and NVIDIA announced a new partnership to build a supercomputer for drug research. Drug manufacturer Eli Lilly and NVIDIA have announced a partnership to build out an AI supercomputer for pharmaceutical research and development.
Heineken’s Harold van den Broek said beer demand remains soft, Tesla’s Vaibhav Taneja flagged tariff drag, Brian Dykes talked UPS’ liquidity and Lucas Montarce lifted Eli Lilly’s outlook.
Weight loss drugs are set to become a disproportionate share of Lilly's business.
GlobalData on MSN
Eli Lilly to invest $3bn in new Dutch manufacturing facility
Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist.
Feedback